Hypofractionated PMRT is safe and effective in breast cancer patients undergoing reconstruction and should be moved into ...

Prior results from the SHAPE trial showed that simple hysterectomy was noninferior to radical hysterectomy for oncologic ...

A machine learning survival model that selects patients for serious illness conversations can increase the rate of advance ...

The FDA has approved Opdivo (nivolumab) as neoadjuvant and adjuvant treatment for adults with resectable NSCLC.

Overall, researchers are estimating that there will be 310,720 new cases of invasive breast cancer and 56,500 new cases of ...

Medicaid expansion was associated with earlier diagnosis, more timely initiation of guideline-concordant care, and better ...

High-dose radiotherapy “needs the addition of short-term ADT to improve outcomes in intermediate- and high-risk localized ...

Zachary W. Schulz, a public health historian, compares Kamala Harris's and Donald Trump's records on health care.

Patients who received subcutaneous daratumumab plus bortezomib, lenalidomide, and dexamethasone (VRd) had better outcomes ...

Zachary W. Schulz, a specialist in public health history and policy, examines both candidates’ records on health care, including drug pricing policies, public health infrastructure, the Affordable ...

The HYPOSIB trial supports moderately hypofractionated radiotherapy with simultaneous boost as a standard-of-care option that ...

Researchers surveyed medical oncology fellows to assess the perceived impact of abortion restrictions on cancer care and how ...